Clinical Chemistry
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 48: 766-767, 2002;
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (17)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Glendenning, P.
Right arrow Articles by Vasikaran, S. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Glendenning, P.
Right arrow Articles by Vasikaran, S. D.
Related Collections
Right arrow Endocrinology and Metabolism
(Clinical Chemistry. 2002;48:766-767.)
© 2002 American Association for Clinical Chemistry, Inc.

Technical Briefs

Parathyroid Hormone Is More Stable in EDTA Plasma Than in Serum

Paul Glendenning1a, Leonie L. A. Laffer1, Hayley K. Weber1, Alexander A. Musk1 and Samuel D. Vasikaran1

1 Department of Core Clinical Pathology and Biochemistry, Royal Perth Hospital, Perth 6000, Western Australia

aauthor for correspondence: fax 618-9224-2491, email Paul.Glendenning@health.wa.gov.au

Measurements of circulating parathyroid hormone (PTH) are important in the evaluation of individuals with hyper- or hypocalcemia and for the investigation of PTH function in bone and mineral disorders (1)(2). Serum may be a good alternative to EDTA plasma in the assessment of PTH status and is an acceptable alternative to EDTA plasma in the reformulated IMMULITE 2000 intact PTH (iPTH) assay. However, reports on the stability of PTH in serum and EDTA plasma are conflicting (3)(4)(5).

Blood samples from 36 patients were collected in parallel into 10-mL tripotassium EDTA tubes, ensuring complete sample filling of the collection vessel (6), and into Becton Dickinson SST II gel separator tubes. PTH was assayed with the reformulated IMMULITE 2000 iPTH assay (beginning with lot L2KPP 106) within 3 h of collection and reassayed on both samples after storage for 3 days at room temperature.

The mean iPTH was 14.8 pmol/L . . . [Full Text of this Article]


Acknowledgments


References




The following articles in journals at HighWire Press have cited this article:


Home page
 J. Clin. Pathol.Home page
P J Twomey, T Whitlock, and D R Pledger
Differences between serum and plasma for intact parathyroid hormone measurement in patients with chronic renal failure in routine clinical practice
J. Clin. Pathol., September 1, 2005; 58(9): 1000 - 1001.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
D. T. Holmes, A. Levin, B. Forer, and F. Rosenberg
Preanalytical Influences on DPC IMMULITE 2000 Intact PTH Assays of Plasma and Serum from Dialysis Patients
Clin. Chem., May 1, 2005; 51(5): 915 - 917.
[Full Text] [PDF]

Home page
 Clin. Chem.Home page
V. Scharnhorst, J. Valkenburg, C. Vosters, and H. Vader
Influence of Preanalytical Factors on the Immulite Intact Parathyroid Hormone Assay
Clin. Chem., May 1, 2004; 50(5): 974 - 975.
[Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2002 by the American Association for Clinical Chemistry.